A. D’Addio

发表

The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT

H. Einsele, D. Niederwieser, W. Rabitsch, 2009, Bone Marrow Transplantation.

acute myeloid leukemia patients ligand-mismatched natural killer cells after infusion in elderly high risk Successful transfer of alloreactive haploidentical KIR

M. Baccarani, L. Ruggeri, A. Velardi, 2011 .

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.

M. Baccarani, L. Ruggeri, A. Velardi, 2011, Blood.

Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging.

M. Baccarani, P. Zinzani, R. Conte, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA

C. Scheid, T. Masszi, A. Rahemtulla, 2012, Bone Marrow Transplantation.

The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF

M. Baccarani, H. Agis, A. Curti, 2011, Bone Marrow Transplantation.

Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient‐specific tumour idiotype protein or idiotype (VDJ)‐derived class I‐restricted peptides

M. Baccarani, R. Conte, P. Comoli, 2007, British journal of haematology.

Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.

H. Einsele, D. Niederwieser, W. Rabitsch, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase

S. Pileri, M. Baccarani, M. Aluigi, 2007, Leukemia.

Hematopoietic stem cell mobilization

R. Lemoli, A. D’Addio, 2008, Haematologica.

Impact of comorbidities and body mass index on the outcome of polycythemia vera patients

R. Latagliata, F. Lanza, A. Cuneo, 2020, Hematological oncology.

BU/melphalan and auto-SCT in AML patients in first CR: a ‘Gruppo Italiano Trapianto di Midollo Osseo (GITMO)’ retrospective study

P. Galieni, A. Bosi, L. Pezzullo, 2010, Bone Marrow Transplantation.

Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?

R. Lemoli, A. D’Addio, 2011, Revista brasileira de hematologia e hemoterapia.